Results 71 to 80 of about 96,219 (310)

Prescribing in First Episode Psychosis

BJPsych Open
Aims This audit aimed to review prescribing in First Episode Psychosis (FEP) in Gloucestershire Health and Care NHS Trust, against NICE guidelines (CG 178) we hoped to develop prescribing guidelines for the Trust and to compare our results with Avon and
Edita Searle, Raeema Patel, Robertson Macpherson   +2 more
doaj   +1 more source

10-minute consultation: First episode psychosis [PDF]

BMJ, 2001
This is part of a series of occasional articles on common problems in primary care A 17 year old man complains of sleep problems and bad dreams. He has recently given up his college course and spends his days alone in his bedroom reading science fiction and fantasy books.
openaire   +2 more sources

Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers [PDF]

, 2015
Magnetic resonance imaging-based markers of schizophrenia have been repeatedly shown to separate patients from healthy controls at the single-subject level, but it remains unclear whether these markers reliably distinguish schizophrenia from mood ...
Borgwardt, Stefan, Davatzikos, Christos, Falkai, Peter, Frodl, Thomas, Kambeitz, Joseph, Koutsouleris, Nikolaos, Köhler, Yanis, Meisenzahl, Eva M., Möller, Hans-Jürgen, Reiser, Maximilian, Riecher-Rössler, Anita   +10 more
core   +1 more source

Rüdin's Unpublished Family Study From the Early 1920s: “On the Inheritance of Manic‐Depressive Insanity”

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT Ernst Rüdin, an important and controversial figure in the history of psychiatric genetics, published only one major empirical study on siblings of dementia praecox (DP) probands in 1916. He conducted a parallel study of siblings of probands with manic‐depressive insanity (MDI), but the resulting monograph, written in the early 1920s, was left ...
Kenneth S. Kendler, Astrid Klee
wiley   +1 more source

First episode psychosis following COVID-19 infection: two case reports from Turkey

Psychiatry and Behavioral Sciences, 2022
Introduction: Coronoviruses can reach the brain by various mechanisms and cause neuropsychiatric symptoms. We present two case reports of patients presenting with first episode psychosis after Covid-19 infection to a training and research hospital in ...
Şeyma Sehlikoğlu, Behice Han Almiş
doaj   +1 more source

Recovery and serious mental illness: a review of current clinical and research paradigms and future directions [PDF]

, 2017
Introduction: Recovery from serious mental illness has historically not been considered a likely or even possible outcome. However, a range of evidence suggests the courses of SMI are heterogeneous with recovery being the most likely outcome. One barrier
Hamm, Jay A., Hasson-Ohayon, Ilanit, Huling, Kelsey, Leonhardt, Bethany L., Lysaker, Paul H., McLeod, Hamish J., Roe, David   +6 more
core   +2 more sources

Schizophrenia Genetics Modulates Clinical Depressive Features

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT Schizophrenia (SCZ) genetic liability, quantified by polygenic scores (PGS), may influence clinical phenotypes in major depressive disorder (MDD). We investigated the effect of the SCZ‐PGS derived from the latest SCZ genome‐wide association study (GWAS) on MDD symptom severity, comorbidities, and treatment outcomes.
Alessandro Serretti, Daniel Souery, Siegfried Kasper, Joseph Zohar, Stuart Montgomery, Panagiotis Ferentinos, Dan Rujescu, Raffaele Ferri, Giuseppe Fanelli, Chiara Fabbri, Raffaella Zanardi, Francesco Benedetti, Bernhard T. Baune, Julien Mendlewicz   +13 more
wiley   +1 more source

Hippocampal subregion abnormalities in schizophrenia: A systematic review of structural and physiological imaging studies. [PDF]

, 2018
AimThe hippocampus is considered a key region in schizophrenia pathophysiology, but the nature of hippocampal subregion abnormalities and how they contribute to disease expression remain to be fully determined.
Matsumoto, Mitsuyuki, Nakahara, Soichiro, van Erp, Theo GM   +2 more
core   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, EarlyView.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source

Family Intervention in First-Episode Psychosis

SAGE Open, 2015
Family interventions have produced benefits on clinical and family outcomes in long standing psychosis. However, little is known about the efficacy of such interventions in the early stages of psychosis.
Anvar Sadath, D. Muralidhar, Shivarama Varambally, Justin P. Jose, B. N. Gangadhar   +4 more
doaj   +1 more source